An experimental immunotherapy has beaten aggressive brain tumours in a handful of children, and a personalised version is now ...

Initial clinical results showed that three pediatric and adolescent brain tumor patients, whose conditions did not respond to ...

On Saturday, a 5K run and walk fundraiser brought the Corbin community together to support a young girl and her family as she ...

The FDA's breakthrough therapy designation accelerates the development of B7-H3 targeting CAR-T cell therapy for pediatric diffuse intrinsic pontine glioma (DIPG). Promising phase 1 trial data from ...

Ten-year-old Vivian Sleeth, a Brevard County girl who bravely battled DIPG (diffuse intrinsic pontine glioma) for more than three years, passed away Tuesday. Vivian's story touched the community, ...

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture. Since the late 1990s, when researchers first reported a technique to ...

Researchers from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed new insight into how the most deadly pediatric brain tumor, diffuse intrinsic pontine ...

Diffuse intrinsic pontine glioma (DIPG) may be one of the lesser-known forms of cancer, yet may be one of the most diabolical. DIPG is a cancer of the brain stem that affects mostly children, 200-400 ...

A first-in-human cell therapy trial at Children's National produced four long-term survivors in children with terminal DIPG ...